I have had the pleasure of having two of Kris Matyjaszweski's Ph.D. students work in my laboratory.  In the course of their postdoctoral work with me and subsequent to that, we created new aerosols, developed novel targeted nanoparticles, and produced new polysaccharide drugs.  We also developed approaches using combinatorial chemistry to create nanoparticles that can deliver siRNA.  Their research has led to a number of new entities that are now in clinical trials or are FDA approved for clinical use.  In this talk, we will examine the chemical challenges as well as the practical aspects of bringing chemistry to a point where it can help patients.

Novel drug delivery systems and pharmaceuticals

243rd National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.